seratrodast has been researched along with 6-ketoprostaglandin f1 alpha in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arimura, A; Iwama, T; Koda, A; Kumimoto, M; Nagai, H; Yoshitake, K | 1 |
| Imura, Y; Nishikawa, K; Terashita, Z | 1 |
| Killian, A; Walsh, SW; Wang, Y | 1 |
| Abe, S; Igarashi, T; Kaneko, S; Miyazaki, N; Ohmichi, M; Saitoh, T; Tanaka, H; Teramoto, S | 1 |
1 trial(s) available for seratrodast and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients?
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Anti-Asthmatic Agents; Asthma; Benzoquinones; Creatinine; Eicosanoids; Female; Forced Expiratory Volume; Heptanoic Acids; Humans; Leukotriene E4; Male; Middle Aged; Peak Expiratory Flow Rate; Receptors, Thromboxane; Thromboxane B2 | 1999 |
3 other study(ies) available for seratrodast and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
The effect of three novel thromboxane A2 receptor antagonists (S-1452, AA-2414 and ONO-3708) on the increase in pulmonary pressure caused by Forssman anaphylaxis in guinea-pigs.
Topics: 6-Ketoprostaglandin F1 alpha; Airway Resistance; Anaphylaxis; Animals; Antibodies, Heterophile; Benzoquinones; Bridged Bicyclo Compounds; Bronchoalveolar Lavage Fluid; Fatty Acids, Monounsaturated; Guinea Pigs; Heptanoic Acids; Histamine; Leukocyte Count; Male; Platelet Count; Quinones; Receptors, Prostaglandin; Receptors, Thromboxane; SRS-A; Thromboxane A2; Thromboxane B2 | 1992 |
The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damage.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Benzoquinones; Carotid Artery Thrombosis; Disease Models, Animal; Endothelium, Vascular; Fatty Acids, Monounsaturated; Heptanoic Acids; Male; Platelet Aggregation; Pyridines; Quinones; Rabbits; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1990 |
AA-2414, an antioxidant and thromboxane receptor blocker, completely inhibits peroxide-induced vasoconstriction in the human placenta.
Topics: 6-Ketoprostaglandin F1 alpha; Antioxidants; Benzoquinones; Blood Pressure; Dose-Response Relationship, Drug; Female; Fetus; Heptanoic Acids; Humans; In Vitro Techniques; Peroxides; Placenta; Pregnancy; Receptors, Thromboxane; Regional Blood Flow; Thromboxane B2; Vascular Resistance; Vasoconstriction | 1999 |